0

IN THIS ISSUE

JAMA: The Journal of the American Medical Association

January 9, 2002, Vol 287, No. 2
Basic View  |  Expanded View
Meetings of Medical Interest FREE
Topics:
JAMA. 2002;287(2):250-254.  doi: 10-1001/pubs.JAMA-ISSN-0098-7484-287-2-jrd0109
The Morning AfterThe Morning After
Topics:
JAMA. 2002;287(2):161-162.  doi: 10.1001/jama.287.2.161
Maternal Cigarette Smoking, Metabolic Gene Polymorphism, and Infant Birth Weight FREE
Xiaobin Wang, MD, MPH, ScD; Barry Zuckerman, MD; Colleen Pearson, BA; Gary Kaufman, MD; Changzhong Chen, MD; Guoying Wang, MD, PhD; Tianhua Niu, ScD; Paul H. Wise, MD, MPH; Howard Bauchner, MD; Xiping Xu, MD, PhD, MS
Topics: smoking, polymorphism, birth weight, cytochrome p-450 cyp1a1, genes, genotype, mothers
JAMA. 2002;287(2):195-202.  doi: 10.1001/jama.287.2.195
National Trends in the Outpatient Treatment of Depression FREE
Mark Olfson, MD, MPH; Steven C. Marcus, PhD; Benjamin Druss, MD; Lynn Elinson, PhD; Terri Tanielian, MA; Harold Alan Pincus, MD
Topics: pharmacotherapy, antidepressive agents, ambulatory care services, depressive disorder, psychotherapy
JAMA. 2002;287(2):203-209.  doi: 10.1001/jama.287.2.203
Sex-Based Analysis of Outcome in Patients With Acute Myocardial Infarction Treated Predominantly With Percutaneous Coronary Intervention FREE
Julinda Mehilli, MD; Adnan Kastrati, MD; Josef Dirschinger, MD; Jürgen Pache, MD; Melchior Seyfarth, MD; Rudolf Blasini, MD; Donald Hall, MD; Franz-Josef Neumann, MD; Albert Schömig, MD
Topics: myocardial infarction, acute, percutaneous coronary intervention, reperfusion therapy
JAMA. 2002;287(2):210-215.  doi: 10.1001/jama.287.2.210
Serum Estradiol Level and Risk of Breast Cancer During Treatment With Raloxifene FREE
Steven R. Cummings, MD; Tu Duong, MA; Emily Kenyon, PhD; Jane A. Cauley, DrPH; Malcolm Whitehead, MB,BS, FRCOG; Kathryn A. Krueger, MD; for the Multiple Outcomes of Raloxifene Evaluation (MORE) Trial
Topics: estradiol, raloxifene, breast cancer, breast cancer risk
JAMA. 2002;287(2):216-220.  doi: 10.1001/jama.287.2.216
Prevalence of Kaposi Sarcoma–Associated Herpesvirus Infection in Homosexual Men at Beginning of and During the HIV Epidemic FREE
Dennis H. Osmond, PhD; Susan Buchbinder, MD; Amber Cheng, MPH; Alison Graves, MPH; Eric Vittinghoff, PhD; Cynthia K. Cossen, BS; Bagher Forghani, PhD; Jeffrey N. Martin, MD, MPH
Topics: hiv, human herpesvirus 8, male homosexuality, infection, epidemic
JAMA. 2002;287(2):221-225.  doi: 10.1001/jama.287.2.221
Defining and Assessing Professional Competence FREE
Ronald M. Epstein, MD; Edward M. Hundert, MD
Topics: professional competence, competence
JAMA. 2002;287(2):226-235.  doi: 10.1001/jama.287.2.226
Clinician's Corner
Corticosteroid Supplementation for Adrenal Insufficiency
Douglas B. Coursin, MD; Kenneth E. Wood, DO
Topics:
JAMA. 2002;287(2):236-240.  doi: 10.1001/jama.287.2.236
Differential Influence of Maternal Smoking on Infant Birth Weight: Title and subTitle BreakGene-Environment Interaction and Targeted Intervention
George P. Vogler, PhD; Lynn T. Kozlowski, PhD
Topics: birth weight, smoking in pregnancy, gene-environment interaction
JAMA. 2002;287(2):241-242.  doi: 10.1001/jama.287.2.241
Competence Is a Habit
David C. Leach, MD
Topics: habits, competence
JAMA. 2002;287(2):243-244.  doi: 10.1001/jama.287.2.243
Ramipril and Risk of Diabetes
A. H. Shlossberg, MD, FRCPC
Topics:
JAMA. 2002;287(2):186-187.  doi: 10-1001/pubs.JAMA-ISSN-0098-7484-287-2-jlt0109
Ramipril and Risk of Diabetes
Darryl K. Potyk, MD
Topics:
JAMA. 2002;287(2):186-187.  doi: 10-1001/pubs.JAMA-ISSN-0098-7484-287-2-jlt0109
Ramipril and Risk of DiabetesRamipril and Risk of Diabetes
Topics:
JAMA. 2002;287(2):186-187.  doi: 10-1001/pubs.JAMA-ISSN-0098-7484-287-2-jlt0109
Ramipril and Risk of Diabetes—Reply
Salim Yusuf, DPhil, FRCPC
Topics:
JAMA. 2002;287(2):186-187.  doi: 10-1001/pubs.JAMA-ISSN-0098-7484-287-2-jlt0109
Are Weekly Courses of Antenatal Steroids Beneficial or Dangerous?
Julian L. Ambrus, MD, PhD; Clara M. Ambrus, MD, PhD
Topics:
JAMA. 2002;287(2):187-190.  doi: 10-1001/pubs.JAMA-ISSN-0098-7484-287-2-jlt0109
Are Weekly Courses of Antenatal Steroids Beneficial or Dangerous?
Kellie E. Murphy, MD, MSc, FRCSC; Mary Hannah, MDCM, FRCSC; Peter Brocklehurst, MBChB, MRCOG, MSc(Epid)
Topics:
JAMA. 2002;287(2):187-190.  doi: 10-1001/pubs.JAMA-ISSN-0098-7484-287-2-jlt0109
Are Weekly Courses of Antenatal Steroids Beneficial or Dangerous?
Thomas M. Jenkins, MD; Ronald J. Wapner, MD; Elizabeth A. Thom, PhD; Anita F. Das, PhD; Catherine Y. Spong, MD
Topics:
JAMA. 2002;287(2):187-190.  doi: 10-1001/pubs.JAMA-ISSN-0098-7484-287-2-jlt0109
Are Weekly Courses of Antenatal Steroids Beneficial or Dangerous?—Reply
Debra A. Guinn, MD; M. Wendy Atkinson, MD; Lisa Sullivan, PhD; MenJean Lee, MD; Scott McGregor, MD; Barbara V. Parilla, MD; Jill Davies, MD; Kathleen Hanlon-Lundberg, MD; Lynn Simpson, MD; Joanne Stone, MD; Deborah Wing, MD; Keith Ogasawara, MD; Jonathon Muraskas, MD
Topics:
JAMA. 2002;287(2):187-190.  doi: 10-1001/pubs.JAMA-ISSN-0098-7484-287-2-jlt0109
Cost-effectiveness of Homocysteine-Lowering Therapy to Prevent Coronary Heart Disease
Len Pogach, MD, MBA
Topics:
JAMA. 2002;287(2):190-192.  doi: 10-1001/pubs.JAMA-ISSN-0098-7484-287-2-jlt0109
Cost-effectiveness of Homocysteine-Lowering Therapy to Prevent Coronary Heart Disease
Gere Sunder-Plassmann, MD; Manuela Födinger, MD
Topics:
JAMA. 2002;287(2):190-192.  doi: 10-1001/pubs.JAMA-ISSN-0098-7484-287-2-jlt0109
Cost-effectiveness of Homocysteine-Lowering Therapy to Prevent Coronary Heart Disease
Andrew G. Bostom, MD, MS
Topics:
JAMA. 2002;287(2):190-192.  doi: 10-1001/pubs.JAMA-ISSN-0098-7484-287-2-jlt0109
Sickle Cell Gene Therapy
Topics: gene therapy, drepanocytes
JAMA. 2002;287(2):180-180.  doi: 10.1001/jama.287.2.180
Methicillin-Resistant FREE
Topics: centers for disease control and prevention (u.s.), methicillin, refugees
JAMA. 2002;287(2):181-182.  doi: 10.1001/jama.287.2.181
Abstract Art in Five Tones and ComplementariesAbstract Art in Five Tones and Complementaries
Topics:
JAMA. 2002;287(2):159-159.  doi: 10.1001/jama.287.2.159
ApoptosisApoptosis
Topics:
JAMA. 2002;287(2):163-163.  doi: 10.1001/jama.287.2.163
THE BIBLIOGRAPHIA MEDICA.THE BIBLIOGRAPHIA MEDICA.
Topics:
JAMA. 2002;287(2):164-164.  doi: 10.1001/jama.287.2.164
Research Yields Clues to Improving Cell Therapy for Parkinson Disease
Topics: parkinson disease, cell therapy
JAMA. 2002;287(2):175-176.  doi: 10.1001/jama.287.2.175
Adolescent PsychotherapyAdolescent Psychotherapy
Topics:
JAMA. 2002;287(2):245-245.  doi: 10.1001/jama.287.2.245
Incorrect Date
Topics:
JAMA. 2002;287(2):192-192.  doi: 10.1001/jama.287.2.192
Incorrect Wording
Topics:
JAMA. 2002;287(2):192-192.  doi: 10.1001/jama.287.2.192
Incorrect Wording and Omissions
Topics:
JAMA. 2002;287(2):192-192.  doi: 10.1001/jama.287.2.192
January 9, 2002January 9, 2002 FREE
Topics:
JAMA. 2002;287(2):255-256.  doi: 10.1001/jama.287.2.255
Meetings of Medical Interest
Topics:
JAMA. 2002;287(2):250-254.  doi: 10-1001/pubs.JAMA-ISSN-0098-7484-287-2-jrd0109

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

© 2012 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems